feed,title,long_url,short_url
SSRN,Single Ad26.COV2.S Booster Dose Following Two Doses of BBIBP-CorV Vaccine Against SARS-CoV-2 Infection in Adults: Day 28 Results of a Phase 1/2 Open-Label Trial,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4387512,
